RH (RH)
(Real Time Quote from BATS)
$340.80 USD
-8.13 (-2.33%)
Updated Sep 20, 2024 09:58 AM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
Income Statements
Fiscal Year end for RH falls in the month of January .
All items in Millions except EPS data.
1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 | |
---|---|---|---|---|---|
Sales | 3,029 | 3,590 | 3,759 | 2,849 | 2,647 |
Cost Of Goods | 1,640 | 1,778 | 1,903 | 1,523 | 1,552 |
Gross Profit | 1,389 | 1,812 | 1,855 | 1,326 | 1,095 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,023 | 1,090 | 928 | 859 | 732 |
Income After Depreciation & Amortization | 366 | 722 | 927 | 467 | 363 |
Non-Operating Income | -1 | -170 | -32 | -20 | -6 |
Interest Expense | 198 | 113 | 65 | 69 | 87 |
Pretax Income | 167 | 439 | 830 | 377 | 269 |
Income Taxes | 28 | -91 | 134 | 105 | 49 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | -11 | -2 | -8 | -1 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 128 | 529 | 689 | 272 | 220 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 128 | 529 | 689 | 272 | 220 |
Depreciation Footnote | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 572 | 906 | 1,069 | 610 | 505 |
Depreciation & Amortization (Cash Flow) | 206 | 184 | 142 | 143 | 142 |
Income After Depreciation & Amortization | 366 | 722 | 927 | 467 | 363 |
Earnings Per Share Data | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Average Shares | 21.60 | 26.56 | 31.11 | 27.30 | 24.30 |
Diluted EPS Before Non-Recurring Items | 6.87 | 20.06 | 26.12 | 17.83 | 11.66 |
Diluted Net EPS (GAAP) | 5.91 | 19.90 | 22.13 | 9.96 | 9.07 |
Fiscal Year end for RH falls in the month of January .
All items in Millions except EPS data.
7/31/24 | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 | |
---|---|---|---|---|---|
Sales | 829.66 | 726.96 | 738.26 | 751.23 | 800.48 |
Cost Of Goods | 454.90 | 410.92 | 417.31 | 410.78 | 420.41 |
Gross Profit | 374.76 | 316.04 | 320.95 | 340.45 | 380.07 |
SG&A, R&D, and Dept/Amort Expenses | 278.63 | 261.38 | 256.70 | 289.21 | 228.73 |
Income After SG&A, R&D, and Dept/Amort Expenses | 96.13 | 54.66 | 64.25 | 51.24 | 151.34 |
Non-Operating Income | 0.66 | -1.17 | 3.39 | -5.31 | 0.19 |
Interest Expense | 59.26 | 56.77 | 59.42 | 54.64 | 44.42 |
Pretax Income | 37.53 | -3.27 | 8.23 | -8.71 | 107.10 |
Income Taxes | 3.72 | -2.09 | -6.35 | -9.22 | 27.25 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | -4.86 | -2.44 | -3.20 | -2.69 | -3.38 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 28.95 | -3.63 | 11.38 | -2.19 | 76.48 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 28.95 | -3.63 | 11.38 | -2.19 | 76.48 |
Earnings Per Share Data | 7/31/24 | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 |
---|---|---|---|---|---|
Average Shares | 19.96 | 18.33 | 19.90 | 18.37 | 22.73 |
Diluted EPS Before Non-Recurring Items | 1.69 | -0.40 | 0.72 | -0.42 | 3.93 |
Diluted Net EPS (GAAP) | 1.45 | -0.20 | 0.91 | -0.12 | 3.36 |